| Background:At present, the clinical to the non-small cell lung cancer (NSCLC) are mainly based in traditional Chinese medicine traditional Chinese and western medicine treatment, Chinese medicine is unique in its efficacy and less side effects and popular. Chinese medicine treatment is the key to differentiation. Each use of the current standard of differentiation is not uniform, the distribution of the reported syndromes are very different, thus affecting the clinical treatment of NSCLC and clinical efficacy of the increase in advanced lung cancer as a result of lack of understanding of the characteristics of the clinical syndrome and distribution of law, in fact, the treatment of lung cancer also affect the development of Chinese medicine. Therefore, to further the adoption of forward-looking, large sample, multi-center study of NSCLC patients with type distribution of the cards is an important clinical significance.Objective:Through the retrospective analysis non-small cell lung cancer with TCM syndrome type TNM staging, pathological type, tumor serum marker and hemoglobin factors, this paper discusses the relationship of TCM syndrome type distribution regularity, and provide reference for clinical diagnosis for non-small cell lung cancer diagnosis and treatment of TCM reference opinions.Methods:First, Guangzhou University of Traditional Chinese Medicine Clinical School of Medicine Oncology Center in January 2007-2009 years in April non-small cell lung cancer patients (about 50 cases, based on inclusion and exclusion criteria subject) for research into this topic. Carried out in accordance with the relevant evidence-based data to TNM staging, pathological type, tumor serum markers, KPS score and other factors are classified and analysis of relevant data.Results:1,Non-small cell lung cancer pathological types and TCM syndrome type, the relationship is squamous cell carcinoma with lung yu phlegm and blood stasis, Yin phlegmy heat with squamous cell carcinoma of the majority, qi-yin deficiency in adenocarcinoma。2,For general situation of patients (PS), physically worst score with qi and Yin Yin deficiency, for pixu phlegmy wet phlegmy heat, and lung yu phlegm stasis.3,and in different syndromes bare there exist significant differences between lung yu phlegm stasis slightly lower than normal the bare, than any other card type is bare; And spleen phlegmy wet and deficiency of phlegmy heat value range in mild bare anemia, qi and Yin deficiency syndrome type of bare in moderate or severe anemia.4,bare CA125 value and the higher the value, the CEA value is lower, the diagnosis of lung yu phlegm stasis; the possibility of type, Bare and the higher the value, the CEA CA125 value is lower, the diagnosis of pixu phlegmy wet type likelihood, The higher the value, the CEA CA125 bare, lower value, qi and Yin deficiency of possibility is very large.Conclusion:The present-day treatment for lung cancer surgery, radiotherapy and chemotherapy, such as gene and comprehensive treatment of Chinese medicine based on the evaluation of lung cancer not only by tumor size as a standard, at the same time to assess the quality and survival with the survival time has been accepted by the medical, Chinese medicine treatment and survival with better quality, the characteristics of a longer survival time. Lung cancer by TCM typing, TNM staging and pathologic tumor classification and the relationship between serum markers of the preliminary study in guiding clinical treatment, to determine the value of disease prognosis, at the same time open up new treatment options to enhance the efficacy of. The surface initial stages with the pathological TNM classification and tumor markers in serum and TCM Syndrome There is a certain relationship between the TCM syndrome differentiation can be used as one of the objective basis。... |
PDF Full Text Request